Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation

Published:2024-07 Issue:7 Volume:50 Page:108429
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Auer Timo Alexander^ORCID,Anhamm Melina,Böning Georg^ORCID,Fehrenbach Uli^ORCID,Schöning Wenzel,Lurje Georg,Gebauer Bernhard^ORCID,Collettini Federico

Publisher

Elsevier BV

Reference22 articles.

1. Global cancer statistics 2020: GLOBOCAN Estimates of Incidence and mortality worldwide for 36 cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update;Reig;J Hepatol,2022

3. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

4. Electronic address eee, European Association for the study of the L. EASL clinical Practice guidelines: management of hepatocellular carcinoma;J Hepatol,2018

5. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection;Feng;Eur Radiol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP